Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop

Simvastatin induces G1 arrest by up-regulating GSK3β and down-regulating CDK4/cyclin D1 and CDK2/cyclin E1 in human primary colorectal cancer cells

(2018) Ming-Jenn Chen et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Antihyperalgesic Properties of Honokiol in Inflammatory Pain Models by Targeting of NF-κB and Nrf2 Signaling

(2018) Sidra Khalid et al.   Frontiers in Pharmacology

Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP

(2016) Xiao-qin Lv et al.   ACTA PHARMACOLOGICA SINICA

Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer withFGFR1amplification: A single-arm, phase 2 study

(2016) Sung Hee Lim et al.   CANCER

Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration

(2016) Poh-Shiow Yeh et al.   CANCER LETTERS

Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy.

(2016) S. Saichaemchan et al.   CURRENT MOLECULAR MEDICINE

Deguelin Induces the Apoptosis of Lung Squamous Cell Carcinoma Cells through Regulating the Expression of Galectin-1

(2016) Bing Yan et al.   International Journal of Biological Sciences

Honokiol inhibits migration of renal cell carcinoma through activation of RhoA/ROCK/MLC signaling pathway

(2016) Shujie Cheng et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Cyclin D1, cancer progression, and opportunities in cancer treatment

(2016) Shuo Qie et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Inorganic polyphosphate promotes cyclin D1 synthesis through activation of mTOR/Wnt/β-catenin signaling in endothelial cells

(2016) S. M. Hassanian et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Enhanced MAPK signaling drives ETS1-mediated induction of miR-29b leading to downregulation of TET1 and changes in epigenetic modifications in a subset of lung SCC

(2016) M A Taylor et al.   ONCOGENE

FGFR as potential target in the treatment of squamous non small cell lung cancer

(2015) Marcello Tiseo et al.   CANCER TREATMENT REVIEWS

FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers

(2015) F. Goke et al.   CLINICAL CANCER RESEARCH

Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor

(2015) Tripti Singh et al.   Oncotarget

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer

(2014) N Cihoric et al.   BRITISH JOURNAL OF CANCER

FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer

(2014) An Na Seo et al.   VIRCHOWS ARCHIV

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer

(2013) F. Andre et al.   CLINICAL CANCER RESEARCH

Fibroblast Growth Factor Receptor 1 as a Putative Therapy Target in Colorectal Cancer

(2013) Friederike Göke et al.   DIGESTION

Downregulation of Sp1 is involved in honokiol-induced cell cycle arrest and apoptosis in human malignant pleural mesothelioma cells

(2013) JUNG-IL CHAE et al.   ONCOLOGY REPORTS

Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy

(2012) S. Arora et al.   CURRENT MOLECULAR MEDICINE

Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo

(2012) Tripti Singh et al.   Epigenetics

β-elemene induces glioma cell apoptosis by downregulating survivin and its interaction with hepatitis B X-interacting protein

(2012) HANG ZHANG et al.   ONCOLOGY REPORTS

MicroRNA-574-5p Was Pivotal for TLR9 Signaling Enhanced Tumor Progression via Down-Regulating Checkpoint Suppressor 1 in Human Lung Cancer

(2012) Qinchuan Li et al.   PLoS One

Caspases and cancer

(2011) M Olsson et al.   CELL DEATH AND DIFFERENTIATION

Fibroblast Growth Factor Signaling in Non–Small-Cell Lung Cancer

(2011) Thomas J. Semrad et al.   Clinical Lung Cancer

Galectin-3 and cyclin D1 expression in non-small cell lung cancer

(2011) Monika Kosacka et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The BCL-2 Family Reunion

(2010) Jerry E. Chipuk et al.   MOLECULAR CELL

The Fibroblast Growth Factor Receptor Inhibitor PD173074 Blocks Small Cell Lung Cancer Growth In vitro and In vivo

(2009) O. E. Pardo et al.   CANCER RESEARCH

Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer

(2008) Hongyu Liu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients

(2008) Rong Li et al.   HUMAN PATHOLOGY